[Standard outcome measures for thymic malignancies]

Zhongguo Fei Ai Za Zhi. 2014 Feb;17(2):122-9. doi: 10.3779/j.issn.1009-3419.2014.02.10.

[Article in Chinese]

Authors

James Huang¹, Frank C Detterbeck², Zuoheng Wang², Patrick J Loehrer³

Affiliations

¹ Division of Thoracic Surgery, Department of Surgery, Yale University School of Medicine and Department of Biostatistics, School of Epidemiology and Public Health, Yale University, New Haven, Connecticut.
² Thoracic Service, Memorial Sloan-Kettering Cancer Center, New York City, New York.
³ HH Gregg Professor of Oncology, Division of Medical Oncology, Department of Internal Medicine, Indiana Universitychool of Medicine, Indianapolis, Indiana.

PMID: 24581163
PMCID: PMC6131238
DOI: 10.3779/j.issn.1009-3419.2014.02.10

No abstract available

Publication types

Review

MeSH terms

Humans
Outcome Assessment, Health Care*
Thymus Neoplasms / drug therapy*
Thymus Neoplasms / mortality
Thymus Neoplasms / pathology
Thymus Neoplasms / surgery*
Treatment Outcome